Chemokines in synovial inflammation in rheumatoid arthritis: basic and clinical aspects

References

• Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675–705.
   PubMed Web of Science ®Google Scholar
• Tani K, Su SB, Utsunomiya I, Oppenheim JJ, Wang JM. Interferon-y maintains the binding and functional capacity of re-ceptors for IL-8 on cultured human T cells. Eur J Immunol 1998;28: 502–7.
   Google Scholar
• Howard OM, Oppenheim JJ, Wang JM. Chemokines as molecular targets for therapeutic invervention. J Clin Immunol 1999;19:280–92.
   Google Scholar
• Ben-Baruch A, Bengali K, Tani K, Xu L, Oppenheim JJ, Wang JM. IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8/CXCL8 receptor type A or type B. Cytokine 1997;9: 37–45.
   Google Scholar
• Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001;250:91–104.
   PubMed Web of Science ®Google Scholar
• Burmester GR, Stuhlmilller B, Keyszer G, Kinne RW. Mono-nuclear phagocytes and rheumatoid synovitis: mastermind or workhorse in arthritis? Arthritis Rheum 1997;40:5–18.
   PubMed Web of Science ®Google Scholar
• Harris ED. Rheumatoid arthritis: pathophysiology and implica-tions for therapy. N Engl J Med 1990;332:1277–82.
   Google Scholar
• Szekanecz Z, Strieter RM, Kunkel SL, Koch AE. Chemokines in rheumatoid arthritis. Springer Semin Immunopathol 1998;20:115–32.
   PubMed Web of Science ®Google Scholar
• Kunkel SL, Lukacs N, Kasama T, Strieter RM. The role of chemokines in inflammatory joint disease. J Leukoc Biol 1996;59:6–12.
   PubMed Web of Science ®Google Scholar
• Opphenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991;9:617–22.
   PubMedGoogle Scholar
• Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, et al. Stromal cell-derived factor-1 - CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000;165: 6590–98.
   Google Scholar
• Hosaka S, Akahoshi T, Wada C, Kondo H. Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol 1994;94:451–7.
   Google Scholar
• Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN. Effect of a CC chemokine receptor antagonist on collagen-induced arthritis in DBA/1 mice. Immunol Lett 1997;57: 117–20.
   Google Scholar
• Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. The receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998;101:746–54.
   PubMed Web of Science ®Google Scholar
• Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F, et al. Persistent induction of the chemokine receptor CXCR4 by TGF-pl on synovial T cells contributes to their accu-mulation within the rheumatoid synovium. J Immunol 2000;165: 3423–9.
   Google Scholar
• Loetscher P, Seitz M, Baggiolini M, Moser B. Interleukin-2 regu-lates CC chemokine receptor expression and chemotactic respon-siveness in T lymphocytes. J Exp Med 1996;184:569–77.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, et al. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur J Immunol 1999;29:2037–45.
   PubMed Web of Science ®Google Scholar
• Katschke KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocyte/macrophages in rheumatoid arthritis. Arthritis Rheum 2001;44:1022–32.
   PubMed Web of Science ®Google Scholar
• Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307–10.
   Google Scholar
• Bromley M, Wooley DE. Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984;27:857–63.
   PubMed Web of Science ®Google Scholar
• Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, et al. Detection of interleukin-8 biological activity in synovial fluids from patients with rheumatoid arthritis and produc-tion of interleukin-8 mFtNA by isolated synovial cells. Eur J Immunol 1990;20:2141–4.
   PubMed Web of Science ®Google Scholar
• Peichl P, Ceska M, Effenberger F, Haberbauer G, Broell H, Lidley IJD. Presence of NAP1/IL-8/CXCL8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 1991;34:333–9.
   PubMed Web of Science ®Google Scholar
• Endo H, Akahoshi T, Takagashi K, Kashiwazaki S, Matsushima K. Evaluation of interleukin-8 levels in joint fluids of patients with rheumatoid arthritis and the induction of leukocyte infiltration and synovitis in rabbit joints. Lymph Cytokine Res 1991;10: 245–52.
   Google Scholar
• Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 1991;87:463–9.
   PubMed Web of Science ®Google Scholar
• Deleuran B, Lemche P, Kristensen M, Chu CQ, Field M, Jensen J, et al. Localisation of interleukin-8 in the synovial membrane, car-tilage-pannus junction and chondrocytes in rheumatoid arthritis. Scand J Ftheumatol 1994;23:2–7.
   PubMed Web of Science ®Google Scholar
• Konig A, Krenn V, Toksoy A, Gerhard N, Glllitzer R. Mig, Gro-ct/ CXCL1 and FtANTES messenger RNA expression in lining layer, infiltrates and different leucocyte populations of synovial tissue from patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Virchows Arch 2000;436: 449–58.
   Google Scholar
• Zvaifler NJ. Macrophages and the synovial lining. Scand J Ftheumatol 1995;101:67–75.
   Google Scholar
• Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, et al. Enhanced production of monocyte chemoat-tractant protein-1 in rheumatoid arthritis. J Clin Invest 1992;90: 772–9.
   PubMed Web of Science ®Google Scholar
• Akahoshi T, Wada C, Endo H, Hirota K, Hosaka S, Takagishi K, et al. Expression of monocyte chemotactic and activating factor in rheumatoid arthritis. Arthritis Rheum 1993;36:762–71.
   PubMed Web of Science ®Google Scholar
• Hayashida K, Nanki T, Girschick H, Yavuz S, Ochi T, Lipsky PE. Synovial stromal cells from rheumatoid arthritis attract monocytes by producing MCP-1 and IL-8. Arthritis Res 2001;3: 118–26.
   PubMedGoogle Scholar
• Kullich W, Klein G. High levels of macrophage inflammatory protein-1 alpha correlate with prolatin in female patients with active rheumatoid arthritis. Clin Ftheumatol 1998;17:263–4.
   PubMedGoogle Scholar
• Janossy G, Panayi GS, Duke 0, Bofi11 M, Poulter LW, Goldstein G. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet 1981;2: 839–42.
   Google Scholar
• Firestein GS, Xu W-D, Townsend K, Broide D, Alvaro-Gracia J, Glasebrook A, et al. Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 1988;168: 1573–86.
   Google Scholar
• Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347–53.
   PubMed Web of Science ®Google Scholar
• Miossec P, Naviliat M, Dupuy d'Angeac A, Sany J, Banchereau J. Low levels of interleukin-4 and high levels of transforming growth factor-n in rheumatoid synovitis. Arthritis Rheum 1990;33: 1180–7.
   Google Scholar
• Chen E, Keystone EC, Fish EN. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1993;36:901–10.
   PubMedGoogle Scholar
• Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989;243: 1464–6.
   Google Scholar
• Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994;91: 3652–6.
   Google Scholar
• Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995;95: 1370–6.
   Google Scholar
• Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Pref-erential migration of activated CD4+ and CD8+ T cells in response to MIP-lct and MIP-1(3. Science 1993;260: 355–8.
   Google Scholar
• Schall TJ, Bacon K, Camp RDR, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein-la (MIP-1a) and MIP-113 chemokines attract distinct populations of lymphocytes. J Exp Med 1993;177: 1821–5.
   Google Scholar
• Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine FtANTES. Nature 1990;347:669–71.
   PubMed Web of Science ®Google Scholar
• Bacon KB, Premack BA, Gardner P, Schall TJ. Activation of dual T cell signaling pathways by the chemokine FtANTES. Science 1995;269:1727–30.
   PubMed Web of Science ®Google Scholar
• Wilkinson PC, Newman I. Identification of interleukin-8 as a loco-motor attractant for activated human lymphocytes in mononuclear cell cultures with anti-CD3 or purified protein derivative of Myco-bacterium tuberculosis. J Immunol 1992;149:2689–94.
   PubMed Web of Science ®Google Scholar
• McInnes IB, al-Mughales J, Field M, Leung BP, Huang FP, Dixon R, et al. The role of interleukin-15 in T-cell migration and activa-tion in rheumatoid arthritis. Nat Med 1996;2: 175–82.
   Google Scholar
• Al-Mughales J, Blyth TH, Hunter JA, Wilkinson PC. The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines. Chin Exp Immunol 1996; 106:230–6.
   Google Scholar
• Moor BB, Keane MP, Addison CL, Arenberg DA, Strieter RM. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J Invest Med 1998;46:113–20.
   Google Scholar
• Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, et al. Human endothelial cells express CCFt2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96:34–40.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immuol 1989;7:145–73.
   PubMed Web of Science ®Google Scholar
• Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227–57.
   PubMed Web of Science ®Google Scholar
• Surcel HM, Troye-Blomberg M, Pantie S, Andersson G, Moreno C, Pasvol G, et al. Thl/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to myco-bacterial antigens. Immunology 1994;81:171–6.
   PubMed Web of Science ®Google Scholar
• Akahoshi M, Nakashima H, Tanaka Y, Kohsaka T, Nagano S, Ohgami E, et al. Thl/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999;42:1644–8.
   PubMed Web of Science ®Google Scholar
• Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s. J Exp Med 1998;187: 129–34.
   Google Scholar
• Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible pro-grams of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875–83.
   PubMed Web of Science ®Google Scholar
• Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Matsushima K, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thy-mus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999;11:81–8.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K. Selective accumulation of CCR5 + T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999;11: 553–9.
   PubMed Web of Science ®Google Scholar
• Mack M, Bruhl H, Gruber R, Jaeger C, Cihak J, Eiter V, et al. Predominance of mononuclear cells expressing the chemokine re-ceptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum 1999;42:981–8.
   PubMed Web of Science ®Google Scholar
• Patel DD, Zachariah JP, Whichard LP. CXCFt3 and CCR5 ligands in rheumatoid arthritis synovium. Chin Immunol 2001;98: 39–45.
   Google Scholar
• Hase K, Tani K, Shimizu T, Matsushima K, Sone S. Increased CCR4 expression in active systemic lupus erythematosus. J Leukoc Biol, 2001;5: 749–55.
   Google Scholar
• Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Sorensen SF, et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Ftheumatol 1998;25:1462–5.
   Google Scholar
• Gomez-Reino JJ, Pablos JL, Carreira PE, Santiago B, Serrano L, Vicario JL, et al. Association of rheumatoid arthritis with a func-tional chemokine receptor CCR5. Arthritis Rheum 1999;42: 989–96.
   Google Scholar
• Cooke Sp, Forrest G, Venables PW, Hajeer A. The 432 deletion of CCR5 receptor in rheumatoid arthritis. Arthritis Rheum 1998;41: 1135–6.
   PubMedGoogle Scholar
• Bar-Shavit R, Kahn A, Fenton II JW, Wilner GD. Chemotactic response of monocytes to thrombin. J Cell Biol 1983;96:282–5.
   Google Scholar
• Luping H, Ogushi F, Tani K, Ogawa H, Kawano T, Endo T, et al. Thrombin promotes fibroblast proliferation during the early stages of experimental radiation pneumonitis. Radiat Res 2001;156:45–52.
   PubMedGoogle Scholar
• Chertov 0, Ueda H, Xu LL, Tani K, Murphy WJ, Wang JM, et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 1997;186: 739–47.
   Google Scholar
• Tani K, Ogushi F, Kido H, Kawano T, Kunori Y, Kamimura T, et al. Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol 2000;67:585–9.
   PubMed Web of Science ®Google Scholar
• Cui P, Tani K, Kitamura H, Okumura Y, Yano M, Inui D, et al. A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes. J Leukoc Biol 75. 2001;70:306–12.
   PubMed Web of Science ®Google Scholar
• Tani K, Ogushi F, Huang L, Kawano T, Tada H, Hariguchi N, et al. CD13/aminopeptidase N: a novel chemoattractant for T lympho-cytes in pulmonary sarcoidosis. Am J Respir Crit Care Med 2000; 76. 161:1636–42.
   Google Scholar
• Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989;83:1299–307.
   PubMed Web of Science ®Google Scholar
• Shipp MA, Look T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood 77. 1993;82:1052–70.
   PubMed Web of Science ®Google Scholar
• Harris CA, Hunte B, Krauss MR, Taylor A, Epstein LB. Induc-tion of leucine aminopeptidase by interferon-gamma. J Biol Chem 78. 1992;267:6865–9.
   Google Scholar
• Turek JJ, Robinson JP. Leucine aminopeptidase activity by flow cytometry. Methods Cell Biol 1994;41:461–7.
   PubMedGoogle Scholar
• Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, 79. McCloskey R, et al. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor a blockade in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:38–47.
   Google Scholar
• Tani K, Ogushi F, Shimizu T, Sone S. Protease-induced leukocyte chemotaxis and activation: roles in host defense and inflammation. J Med Invest 2001;48;133–41.
   PubMedGoogle Scholar
• Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Haines GK, et al. Growth-related gene product alpha: a chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995; 155:3660–6.
   PubMed Web of Science ®Google Scholar
• Kraan MC, de Koster BM, Elferink JG, Post WJ, Breedveld FC, Tak PP. Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheu-matoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients. Arthritis Rheum 2000;43: 1488–95.
   PubMed Web of Science ®Google Scholar
• Gong JH, Ratkay LG, Waterfield JD. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-1pr mouse model. J Exp Med 1997;186: 131–7.
   Google Scholar
• Barnes DA, Tse J, Kaufhold M, Owen M, Hesselgesser J, Strieter R, et al. Polyclonal antibody directed against human FtANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model. J Chin Invest 1998;101:2910–9.
   PubMed Web of Science ®Google Scholar
• Matthys P, Hatse S, Vermeire K, Wuyts A, Bridger G, Henson GW, et al. Amd3100, a potent and specific antagonist of the stro-mal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol 2001;167:4686–92.
   PubMed Web of Science ®Google Scholar